Characteristics | CTXNS-Ena (n = 37) | CTXS-En (n = 74) | P-value |
---|---|---|---|
Empirical therapy | |||
 Third-generation cephalosporins | 5 (14%) | 20 (27%) | 0.15 |
 Other cephems | 10 (27%) | 21 (28%) | 1.00 |
 β-lactam/β-lactamase inhibitors | 11 (30%) | 15 (20%) | 0.34 |
 Carbapenems | 10 (27%) | 16 (22%) | 0.64 |
 Other antibioticsb | 0 (0%) | 2 (3%) | 1.00 |
 Appropriate empirical therapy | 23 (62%) | 66 (89%) | <0.01 |
 Complete response at 72 h | 4 (11%) | 23 (31%) | 0.02 |
 Complete response at 7 days | 23 (62%) | 59 (80%) | 0.07 |
 30-day mortality | 2 (5%) | 2 (3%) | 0.60 |